Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny. See omnystudio.com/listener for privacy information.